子痫前期对母亲哮喘与子代哮喘关系的影响:VDAART临床试验观察
本研究基于VDAART试验806对高风险母婴队列,分析母亲哮喘与子痫前期对3岁儿童哮喘的联合效应。结果显示,母亲单纯哮喘时子代哮喘风险增加(aHR 2.18),合并子痫前期时风险进一步升高(aHR 2.68),且趋势检验显著。
要点
- 母亲哮喘合并子痫前期时,子代3岁内哮喘风险显著高于单纯母亲哮喘。
- 子代哮喘发病率随母亲哮喘和子痫前期状态呈递增趋势(P for trend <0.001)。
- 对于母亲哮喘合并子痫前期者,子代哮喘伴反复喘息风险更高(aHR 4.73)。
核心结论
- 子痫前期在母亲哮喘基础上进一步增加3岁以下子代哮喘风险。
- 结果提示母体因素交互作用及子痫前期相关的宫内免疫与发育失调可能预测子代哮喘。
研究设计与样本
- VDAART临床试验的队列分析,纳入806名孕妇及其子代,从孕10-18周随访至子代3岁。
- 子痫前期由病历回顾、产科医生诊断及产科专家组裁定确定。
- 子代哮喘主要结局由家长报告医生诊断确定,并分析伴反复喘息的哮喘风险。
主要发现
- 3岁子代哮喘发病率:无哮喘无子痫前期组9.90%(44/445),无哮喘有子痫前期组17.95%(7/39),有哮喘无子痫前期组22.11%(65/294),有哮喘有子痫前期组32.14%(9/28)。
- 与无哮喘无子痫前期母亲子代相比,有哮喘无子痫前期母亲子代哮喘aHR为2.18(95%CI 1.46-3.26)。
- 有哮喘有子痫前期母亲子代哮喘aHR为2.68(95%CI 1.30-5.61)。
- 子代哮喘伴反复喘息:有哮喘有子痫前期母亲子代aHR为4.73(95%CI 2.20-10.07;P for trend <0.001)。
临床怎么用
- 对哮喘孕妇应关注子痫前期发生,因其可能进一步增加子代早期哮喘风险。
- 有哮喘合并子痫前期母亲所生子代,尤其伴反复喘息者,需加强哮喘监测与随访。
局限性
- 子代哮喘依据家长报告医生诊断,可能存在报告偏倚。
- 子痫前期亚组样本量较小(如无哮喘有子痫前期组仅39例)。
- 随访仅至子代3岁,不能反映更长远期哮喘结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Maternal asthma and preeclampsia have independently been reported to be associated with increased asthma incidence in children of affected mothers. Maternal asthma is also associated with increased risk of preeclampsia development. However, the joint effect of these maternal conditions on child asthma risk is unknown. OBJECTIVES: To study whether development of preeclampsia among pregnant women with asthma was associated with higher risk of childhood asthma in the VDAART (Vitamin D Antenatal Asthma Reduction Trial). METHODS: A total of 806 pregnant women and their offspring at high risk of asthma or atopy, who were followed from VDAART enrollment (10-18 wk of gestation) through the child's third birthday, were included in this cohort analysis. Preeclampsia status was determined by chart review, obstetrician diagnosis, and adjudication by a panel of obstetricians. Child asthma was the main outcome as determined by parental report of a physician diagnosis, and the risk of child asthma was also examined if accompanied by recurrent wheeze. The main risk variable of interest was a four-level ordered variable defined for each mother, with values without asthma without preeclampsia, without asthma with preeclampsia, with asthma without preeclampsia, and with asthma with preeclampsia during their pregnancy. We examined the trend of outcome proportions across these categories. To account for differences in maternal and child characteristics, we used a Weibull regression model for interval-censored data to compare the incidence of child asthma by age of 3 years across the maternal variable categories. MEASUREMENTS AND MAIN RESULTS: The incidence of asthma in 3-year-old children was 9.90% (44/445), 17.95% (7/39), 22.11% (65/294), and 32.14% (9/28) among those born to mothers without asthma and without preeclampsia, mothers without asthma with preeclampsia, mothers with asthma without preeclampsia, and mothers with asthma with preeclampsia, respectively. The incidences demonstrated an increasing trend in risk of child asthma across the maternal groups (P for trend <0.001). After accounting for potential confounders and using time to report of childhood asthma as analysis outcome, risk of asthma was greater among children born to mothers with asthma without preeclampsia, compared with mothers without asthma without preeclampsia (adjusted hazard ratio, 2.18; 95% confidence interval, 1.46-3.26). This risk was 50% greater for children born to mothers with asthma who developed preeclampsia during pregnancy (adjusted hazard ratio, 2.68; 95% confidence interval, 1.30-5.61). The trend in asthma and recurrent wheeze proportions across the maternal groups' children also indicated a higher risk for children born to mothers with asthma with preeclampsia (adjusted hazard ratio, 4.73; 95% confidence interval, 2.20-10.07; P for trend <0.001). CONCLUSIONS: Preeclampsia is associated with increased risk of early life childhood asthma in children less than 3 years old over and above that associated with maternal asthma alone. The results implicate the interplay between maternal factors as strong predictors of offspring asthma and in utero maternal-fetal immune perturbations and developmental dysregulations associated with preeclampsia.
引用
- Mirzakhani H, Carey VJ, McElrath TF, et al. Impact of Preeclampsia on the Relationship between Maternal Asthma and Offspring Asthma. An Observation from the VDAART Clinical Trial. Am J Respir Crit Care Med. 2019. PMID: 30153046. doi:10.1164/rccm.201804-0770OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。